More on CNSP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CNS Pharmaceuticals (NQ:CNSP)
Delayed: 5.04 +0.30 (6.33%)
Prev. Close $4.74  
Open$4.82 
52 Wk High$ 
52 Wk Low$ 
Day High$5.05 
Day Low$4.66 
P/E N/A  
EPS$ 
Volume7,711 

Friends, Peers and Foes (?): AKTX, AMIX, GRI, MBRX, NUWE (more...)

Jul 2, 2026 07:30 AM Form 8-K CNS Pharmaceuticals, For: Jul 02
Jun 8, 2026 09:15 AM CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment
May 27, 2026 06:04 AM Form EFFECT CNS Pharmaceuticals,
May 26, 2026 05:02 PM Form 424B3 CNS Pharmaceuticals,
May 20, 2026 09:03 AM Form 4 CNS Pharmaceuticals, For: May 18 Filed by: Charles Faith L.
May 19, 2026 05:02 PM Form D CNS Pharmaceuticals,
May 19, 2026 05:00 PM CNS Pharmaceuticals (CNSP) files for 9.79M share offering by selling stockholders
May 19, 2026 04:56 PM Form S-3 CNS Pharmaceuticals,
May 15, 2026 05:14 PM Form SCHEDULE 13G/A CNS Pharmaceuticals, Filed by: Stonepine Capital Management, LLC
May 14, 2026 08:00 AM CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
View All Articles

Entities mentioned with CNSP

View All Entities